Advertisement

NAFLD/NASH Medications

The NAFLD/NASH medications' page includes experimental drugs in later phases of development for treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

*generic or biosimilar available

E experimental


DRUG cenicriviroc
GENERIC NAME cenicriviroc
COMPANY Allergan
DRUG cilofexor
GENERIC NAME N/A
COMPANY Gilead Sciences
DRUG elafibranor
GENERIC NAME elafibranor
COMPANY Genfit
DRUG emricasan
GENERIC NAME emricasan
COMPANY Conatus
DRUG firsocostat
GENERIC NAME N/A
COMPANY Gilead Sciences
DRUG Ocaliva
GENERIC NAME obeticholic acid
COMPANY Intercept Pharmaceuticals
DRUG pegbelfermin
GENERIC NAME pegbelfermin
COMPANY Bristol-Myers Squibb
DRUG selonsertib
GENERIC NAME selonsertib
COMPANY Gilead Sciences
DRUG tropifexor
GENERIC NAME tropifexor
COMPANY Novartis

Last Reviewed: February 4, 2019


Advertisement

Hot topics